title: Evaluation of false positive and false negative outcomes in NTP long-term rodent carcinogenicity studies.
abstract: The decision-making process used by the National Toxicology Program (NTP) in its evaluation of long-term rodent carcinogenicity studies was investigated to determine whether or not this procedure resulted in an excessive number of false positive or false negative outcomes. All site-specific tumor incidences that were found to be significantly (p < 0.05) increased either by a trend test or by pairwise comparisons of each dosed group against the controls in 218 NTP 2-year studies with Fischer 344 rats and/or B6C3F1 mice were tabulated and compared to the number of statistically significant tumor increases expected to occur by chance. Our evaluation suggests that false positive rates are fairly low in NTP long-term studies. Assessing false negative rates is more difficult because of the limited sensitivity of the bioassay for detecting subtle carcinogenic effects. Moreover, reduced body weights frequently occur in dosed animals, and the positive correlation between the incidences of certain site-specific tumors and body weight may mask the detection of carcinogenic effects. Despite these difficulties, our analysis did identify one tumor showing evidence of false negative outcomes: interstitial cell tumors of the testis in male Fischer 344 (F344) rats. This tumor showed considerably more significant (p < 0.05) increased incidences than expected by chance, yet none were considered to be chemically-related. However, the biological significance of interstitial cell tumor increases in F344 rats is uncertain because of the high background rate of neoplasia (> 90%) for this target site.
authors.affiliation: Statistics and Biomathematics Branch, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27709, USA.
authors.forename: J K
authors.initials: JK
authors.lastname: Haseman
authors.forename: M R
authors.initials: MR
authors.lastname: Elwell
mesh_terms: D000818:Animals; D001835:Body Weight; D002273:Carcinogens / Q000008:administration & dosage / Q000009:adverse effects*; D003657:Decision Making; D004195:Disease Models, Animal; D004305:Dose-Response Relationship, Drug; D005069:Evaluation Studies as Topic; D005188:False Negative Reactions; D005189:False Positive Reactions; D005260:Female; D015994:Incidence; D007984:Leydig Cell Tumor / Q000139:chemically induced; D008137:Longitudinal Studies; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D009374:Neoplasms, Experimental / Q000139:chemically induced*; D017063:Outcome Assessment, Health Care; D051381:Rats; D011916:Rats, Inbred F344; D012680:Sensitivity and Specificity; D013736:Testicular Neoplasms / Q000139:chemically induced; D014116:Toxicology; D014481:United States
chemical_list: D002273:Carcinogens